Actionable news
All posts from Actionable news
Actionable news in MYL: Mylan Inc.,

Mylan Profit Tops Analyst Estimates as Generics Sales Rise

Mylan NV, the world’s third-biggest maker of generic drugs, reported profit that topped analysts’ estimates as sales of copycat medicines soared.

Third-quarter profit excluding some items rose to $1.43 a share, beating the $1.38 average of analyst estimates compiled by Bloomberg. Revenue rose 29 percent to $2.7 billion, falling short of analysts’ projected $2.8 billion.

EpiPen, an injection used to treat severe allergic reactions, is Mylan’s biggest product. Sanofi recalled EpiPen’s primary branded rival, Auvi-Q, on Wednesday because of concerns...